Drug discovery typically relies on iterative design-make-purify-test cycles focused on specific, pre-selected protein targets. Here, the authors introduce an algorithm-driven, closed-loop workflow for phenotype-driven discovery which was exemplified through the discovery and structural evolution of a series of tubulin modulators.
- Amalia-Sofia Piticari
- Samuel D. Griggs
- Adam Nelson
